A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2006
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1723960A1 Botanical compositions having oral insulin-like hypoglycemic activity, with hypolipidemic and antimicrobial activities
11/22/2006	EP1723959A1 Composition comprising platelet-rich plasma
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723952A1 Antiwrinkling preparation
11/22/2006	EP1723146A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
11/22/2006	EP1722855A1 Of at use of an antagonist compound of at least one receptor selected from a group comprising beta-adrenergic receptors, a at1, 5-ht5 and galanin receptor for preparing a pharmaceutical composition for treating rosacea
11/22/2006	EP1722813A1 Use of botulinum toxin for preparing a drug for preventing hair growth
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1429756B1 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1370143B1 An antimicrobial composition
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1299081B1 Use of oligosaccharides to stimulate beta-endorphin production
11/22/2006	EP1244401B1 Drug delivery of phase changing formulation
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1096924B1 Inhibitors of proteasomal activity for stimulating hair growth
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867310A Composition and method for promoting hair growth
11/22/2006	CN1865286A Double function epidermal growth factor and its preparation method and uses
11/22/2006	CN1864736A A medicine for treating tinea pedis
11/22/2006	CN1864732A An ointment for treating scalds and burns
11/22/2006	CN1864704A Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain
11/22/2006	CN1864697A Application of non-adenine in preparation of drug for promoting wound healing
11/22/2006	CN1864664A Lmiquimod cream and preparation method thereof
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285352C Adhesive plaster for curing lymph disease, red wound and lump furuncle
11/22/2006	CN1285351C Ointment for treating skin injury and preparation method thereof
11/22/2006	CN1285341C Burns-treating medicine
11/22/2006	CN1285339C Adhesive bandage containing hyaluronic acid biological composition
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2258971C Use of a cosmetic compound for the treatment and prevention of acne rosacea
11/21/2006	CA2247611C Method and composition for hair removal
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2204478C Fluorinated vitamin d3 analogs
11/21/2006	CA2178105C Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
11/21/2006	CA2164061C Cosmetic compositions containing lactate dehydrogenase inhibitors
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006	WO2006122137A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
11/16/2006	WO2006122079A1 Il-31 monoclonal antibodies and methods of use
11/16/2006	WO2006121219A1 Agent for controlling epithelial-mesenchymal transition
11/16/2006	WO2006121210A1 Agent for improving skin condition
11/16/2006	WO2006121209A1 Therapeutic agent for eczema and dermatitis
11/16/2006	WO2006121156A1 Medical composition for promotion of skin regeneration
11/16/2006	WO2006120851A1 Agent for imparting functions to textile products
11/16/2006	WO2006119540A1 Preparation for treating psoriasis
11/16/2006	WO2005089803A3 Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258753 Such as 2-oxo-3-hydroxy-25-ethylidene-A-nor cholest-3-ene; for increasing synthesis of collagen
11/16/2006	US20060258703 Remedy for pruritus comprising piperidine derivative as the active ingredient
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258651 Use of heterocyclic compounds as scce inhibitors
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257456 Material promoting wound healing
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	US20060257351 administering, to a subject a formulation containing2-(3,4-dihydroxyphenyl)ethanol or a glucoside; and cysteine or cystine for potentiating glutathione, for promoting the production of a gamma -glutamylcysteine synthetase, glutathione reductase; antiaging agents, nutraceuticals, sunscreen agents
11/16/2006	US20060257333 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	DE202006014258U1 Formulation, useful for skin cream foam, comprises an aqueous emulsion and a carrier gas, where the emulsion contains urea, hyaluronic acid, a free fatty acid and emulsifying agents
11/16/2006	DE102005022626A1 Cosmetic agent for treating stressed skin comprises an oil-in-water (O/W) emulsion containing taurine and a long-chain linear primary fatty or wax alcohol
11/16/2006	DE102005021806A1 Verwendung von radikalfangenden Substanzen zur Behandlung von Zuständen mit erhöhter Hauttemperatur, insbesondere zur antipyretischen Behandlung Use of free radical scavenging substances for the treatment of conditions with increased skin temperature, especially for antipyretic treatment
11/16/2006	CA2607912A1 Medical composition for promotion of skin regeneration
11/16/2006	CA2607588A1 Il-31 monoclonal antibodies and methods of use
11/15/2006	EP1721905A1 Thiazole derivative
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721601A1 Use of taurine for enhancing lipid synthesis in the epidermis
11/15/2006	EP1720576A1 Photodynamic therapy for the treatment of acne
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1495111A4 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents

1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 1065